Skip to main content
Hit enter to search or ESC to close
Close Search
Menu
About
Company Overview
Leadership
Collaborations
Presentations
Platform
Platform Overview
Publications
Intellectual Property
Pipeline
Pipeline Overview
AGX-A
Cholangiocarcinoma
Age-related macular degeneration (AMD)
Newsroom
Investors
Investor Overview
Press Releases
Company Information
SEC Filings
Stock Information
Corporate Governance
Contact
General Inquiries
Partnership Inquiries
Career Opportunities
Investors
Press Releases
Overview
Press Releases
Company Information
Stock Information
SEC Filings
Corporate Governance
Recent Press Releases
Angiogenex Co-Developing Anti-Cancer Drug With World Renowned Cancer Center
February 13, 2020
Michael Aronstein to Head AngioGenex Board of Directors
December 5, 2017
AngioGenex Newsroom
Recent Media Coverage
What Is Angiogenesis? (via Sloan Kettering Institute)
March 13, 2014
DNA pioneer James Watson takes aim at “cancer establishments” (via Reuters)
January 9, 2013
Opening Cancer’s Black Box (via Sloan Kettering Institute)
June 1, 2010
Close Menu
About
Company Overview
Leadership
Collaborations
Presentations
Platform
Platform Overview
Publications
Intellectual Property
Pipeline
Pipeline Overview
AGX-A
Cholangiocarcinoma
Age-related macular degeneration (AMD)
Newsroom
Investors
Investor Overview
Press Releases
Company Information
SEC Filings
Stock Information
Corporate Governance
Contact
General Inquiries
Partnership Inquiries
Career Opportunities
